Work

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

Year: 1999

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: P A Vasey, S B Kaye, R Morrison, C Twelves, P Wilson, R Duncan, A H Thomson, L S Murray, T E Hilditch, T Murray, S Burtles, D Fraier, E Frigerio, J Cassidy

Institution: Beatson West of Scotland Cancer Centre

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2121429936

FWCI: 22.85

Cites: 38

Cited by: 689

Related to: 10